Shorts On Watch: Is Buying Natus Medical Incorporated (NASDAQ:BABY), Having Higher Short Interest a Winning Strategy?

November 25, 2016 - By Ruchi Gupta   ·   0 Comments

Shorts On Watch: Is Buying Natus Medical Incorporated (NASDAQ:BABY), Having Higher Short Interest a Winning Strategy?

The stock of Natus Medical Incorporated (NASDAQ:BABY) registered an increase of 91.63% in short interest. BABY’s total short interest was 1.70 million shares in November as published by FINRA. Its up 91.63% from 885,400 shares, reported previously. With 496,500 shares average volume, it will take short sellers 3 days to cover their BABY’s short positions. The short interest to Natus Medical Incorporated’s float is 5.43%. The stock closed at $42.45 during the last session. It is down 24.52% since April 22, 2016 and is uptrending. It has outperformed by 19.11% the S&P500.

Natus Medical Incorporated is a provider of newborn care and neurology healthcare services and products used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The company has a market cap of $1.40 billion. The Company’s segment is neurology and newborn care product families. It has a 33.93 P/E ratio. The Company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories.

Insitutional Activity: The institutional sentiment increased to 1.11 in 2016 Q2. Its up 0.04, from 1.07 in 2016Q1. The ratio improved, as 34 funds sold all Natus Medical Inc shares owned while 51 reduced positions. 23 funds bought stakes while 68 increased positions. They now own 28.47 million shares or 0.50% less from 28.61 million shares in 2016Q1.
Point72 Asset L P holds 0.16% of its portfolio in Natus Medical Inc (NASDAQ:BABY) for 622,600 shares. Moreover, Teachers Advsr Inc has 0.02% invested in Natus Medical Inc (NASDAQ:BABY) for 272,269 shares. Huntington Comml Bank has 2,075 shares for 0% of their US portfolio. Motley Fool Wealth Management Limited Liability Co owns 78,466 shares or 0.33% of their US portfolio. Fifth Third Savings Bank last reported 0.01% of its portfolio in the stock. Suntrust Banks Inc owns 5,776 shares or 0% of their US portfolio. The Illinois-based One Trading Ltd Partnership has invested 0% in Natus Medical Inc (NASDAQ:BABY). Pitcairn holds 0.04% or 8,303 shares in its portfolio. Ls Investment Limited Liability accumulated 0% or 1,353 shares. Pax Management Ltd Liability has 430,000 shares for 0.94% of their US portfolio. Anderson Hoagland last reported 0.97% of its portfolio in the stock. Strs Ohio has invested 0% of its portfolio in Natus Medical Inc (NASDAQ:BABY). Tci Wealth Advsr, a Arizona-based fund reported 45 shares. Alphamark Advsrs Ltd Liability has 0.52% invested in the company for 23,320 shares. Prudential Inc owns 98,391 shares or 0.01% of their US portfolio.

Insider Transactions: Since September 28, 2016, the stock had 2 buys, and 2 selling transactions for $621,746 net activity. On Monday, October 24 the insider GUNST ROBERT A sold $136,237. HAWKINS JAMES B bought 10,000 shares worth $384,840. Shares for $1.25 million were sold by Kennedy Jonathan.

Natus Medical Inc (NASDAQ:BABY) Ratings Coverage

Out of 4 analysts covering Natus Medical (NASDAQ:BABY), 4 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Natus Medical has been the topic of 6 analyst reports since July 23, 2015 according to StockzIntelligence Inc. Roth Capital maintained the shares of BABY in a report on Tuesday, April 5 with “Buy” rating. Raymond James upgraded the shares of BABY in a report on Tuesday, September 13 to “Outperform” rating. The firm has “Buy” rating by TH Capital given on Thursday, July 23. Benchmark initiated it with “Buy” rating and $55 target price in Tuesday, October 4 report. TH Capital maintained Natus Medical Inc (NASDAQ:BABY) on Thursday, October 22 with “Buy” rating. The firm has “Buy” rating by TH Capital given on Tuesday, January 12.

BABY Company Profile

Natus Medical Incorporated, incorporated on July 20, 2000, is a well-known provider of newborn care and neurology healthcare services and products used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company’s segment is neurology and newborn care product families. The Company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. The Firm is organized into two strategic business units: Neurology and Newborn Care.

More notable recent Natus Medical Inc (NASDAQ:BABY) news were published by: Fool.com which released: “Why Natus Medical Inc Slipped Today” on September 26, 2016, also Fool.com with their article: “Natus Medical Inc.: This BABY Keeps Chugging Along” published on October 20, 2016, Fool.com published: “3 Things to Watch As Natus Medical Inc Reports Earnings” on July 18, 2016. More interesting news about Natus Medical Inc (NASDAQ:BABY) were released by: Fool.com and their article: “Why Natus Medical Inc. Reported Lower Today” published on April 04, 2016 as well as Fool.com‘s news article titled: “How Natus Medical Inc. Got Back on Track” with publication date: July 20, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Ruchi Gupta


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>